A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice

S. D. Freedman, M. H. Katz, E. M. Parker, Michael Laposata, M. Y. Urman, J. G. Alvarez

Research output: Contribution to journalArticle

234 Citations (Scopus)

Abstract

A deficiency in essential fatty acid metabolism has been reported in plasma from patients with cystic fibrosis (CF). However, its etiology and role in the expression of disease is unknown. The objective of this study was to determine whether alterations in fatty acid metabolism are specific to CF- regulated organs and whether they play a role in the expression of disease. A membrane lipid imbalance was found in ileum, pancreas, and lung from cftr(-/- ) mice characterized by an increase in phospholipid-bound arachidonic acid and a decrease in phospholipid-bound docosahexaenoic acid (DHA). This lipid imbalance was observed in organs pathologically affected by CF including lung, pancreas, and ileum and was not secondary to impaired intestinal absorption or hepatic biosynthesis of DHA. As proof of concept, oral administration of DHA to cftr(-/-) mice corrected this lipid imbalance and reversed the observed pathological manifestations. These results strongly suggest that certain phenotypic manifestations of CF may result from remediable alterations in phospholipid-bound arachidonic acid and DHA levels.

Original languageEnglish (US)
Pages (from-to)13995-14000
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number24
DOIs
StatePublished - Nov 23 1999
Externally publishedYes

Fingerprint

Docosahexaenoic Acids
Membrane Lipids
Cystic Fibrosis
Phospholipids
Ileum
Arachidonic Acid
Pancreas
Lipids
Lung
Essential Fatty Acids
Intestinal Absorption
Oral Administration
Fatty Acids
Liver

Keywords

  • Arachidonic acid
  • Docosahexaenoic acid
  • Fish oil
  • Lung
  • Pancreas

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. / Freedman, S. D.; Katz, M. H.; Parker, E. M.; Laposata, Michael; Urman, M. Y.; Alvarez, J. G.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 24, 23.11.1999, p. 13995-14000.

Research output: Contribution to journalArticle

@article{221f2d48903741a0851d60ce4c32d780,
title = "A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice",
abstract = "A deficiency in essential fatty acid metabolism has been reported in plasma from patients with cystic fibrosis (CF). However, its etiology and role in the expression of disease is unknown. The objective of this study was to determine whether alterations in fatty acid metabolism are specific to CF- regulated organs and whether they play a role in the expression of disease. A membrane lipid imbalance was found in ileum, pancreas, and lung from cftr(-/- ) mice characterized by an increase in phospholipid-bound arachidonic acid and a decrease in phospholipid-bound docosahexaenoic acid (DHA). This lipid imbalance was observed in organs pathologically affected by CF including lung, pancreas, and ileum and was not secondary to impaired intestinal absorption or hepatic biosynthesis of DHA. As proof of concept, oral administration of DHA to cftr(-/-) mice corrected this lipid imbalance and reversed the observed pathological manifestations. These results strongly suggest that certain phenotypic manifestations of CF may result from remediable alterations in phospholipid-bound arachidonic acid and DHA levels.",
keywords = "Arachidonic acid, Docosahexaenoic acid, Fish oil, Lung, Pancreas",
author = "Freedman, {S. D.} and Katz, {M. H.} and Parker, {E. M.} and Michael Laposata and Urman, {M. Y.} and Alvarez, {J. G.}",
year = "1999",
month = "11",
day = "23",
doi = "10.1073/pnas.96.24.13995",
language = "English (US)",
volume = "96",
pages = "13995--14000",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "24",

}

TY - JOUR

T1 - A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice

AU - Freedman, S. D.

AU - Katz, M. H.

AU - Parker, E. M.

AU - Laposata, Michael

AU - Urman, M. Y.

AU - Alvarez, J. G.

PY - 1999/11/23

Y1 - 1999/11/23

N2 - A deficiency in essential fatty acid metabolism has been reported in plasma from patients with cystic fibrosis (CF). However, its etiology and role in the expression of disease is unknown. The objective of this study was to determine whether alterations in fatty acid metabolism are specific to CF- regulated organs and whether they play a role in the expression of disease. A membrane lipid imbalance was found in ileum, pancreas, and lung from cftr(-/- ) mice characterized by an increase in phospholipid-bound arachidonic acid and a decrease in phospholipid-bound docosahexaenoic acid (DHA). This lipid imbalance was observed in organs pathologically affected by CF including lung, pancreas, and ileum and was not secondary to impaired intestinal absorption or hepatic biosynthesis of DHA. As proof of concept, oral administration of DHA to cftr(-/-) mice corrected this lipid imbalance and reversed the observed pathological manifestations. These results strongly suggest that certain phenotypic manifestations of CF may result from remediable alterations in phospholipid-bound arachidonic acid and DHA levels.

AB - A deficiency in essential fatty acid metabolism has been reported in plasma from patients with cystic fibrosis (CF). However, its etiology and role in the expression of disease is unknown. The objective of this study was to determine whether alterations in fatty acid metabolism are specific to CF- regulated organs and whether they play a role in the expression of disease. A membrane lipid imbalance was found in ileum, pancreas, and lung from cftr(-/- ) mice characterized by an increase in phospholipid-bound arachidonic acid and a decrease in phospholipid-bound docosahexaenoic acid (DHA). This lipid imbalance was observed in organs pathologically affected by CF including lung, pancreas, and ileum and was not secondary to impaired intestinal absorption or hepatic biosynthesis of DHA. As proof of concept, oral administration of DHA to cftr(-/-) mice corrected this lipid imbalance and reversed the observed pathological manifestations. These results strongly suggest that certain phenotypic manifestations of CF may result from remediable alterations in phospholipid-bound arachidonic acid and DHA levels.

KW - Arachidonic acid

KW - Docosahexaenoic acid

KW - Fish oil

KW - Lung

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=0033598714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033598714&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.24.13995

DO - 10.1073/pnas.96.24.13995

M3 - Article

VL - 96

SP - 13995

EP - 14000

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 24

ER -